Maryland Invests $7M in Innovation Grants to Boost Tech Infrastructure

On June 8, 2026, Maryland Governor Wes Moore unveiled nearly $7 million in funding through the Build Our Future Grant Program aimed at enhancing the state's innovation infrastructure. This strategic allocation is targeted at supporting 11 projects across private sector companies, nonprofits, local governments, and academic institutions, all focusing on pivotal technology sectors such as biotechnology, aerospace, artificial intelligence, and clean energy. The Maryland Department of Commerce alongside the Maryland Economic Development Corporation (MEDCO) is responsible for managing this funding, which not only aims to advance the state's technological capabilities but also to support job creation and economic growth in the region.

The grants, part of the Governor's Innovation Economy Infrastructure Act of 2023, highlight the state’s commitment to cultivating a competitive economic landscape. By investing up to $2 million per project, the program encourages initiatives that span advanced manufacturing, cybersecurity, and life sciences, aimed at fostering a diverse technological ecosystem. Governor Moore emphasized the importance of this investment stating, "Building a stronger, more competitive Maryland economy requires strategic investment in the businesses and industries that will drive growth in the coming years."

These grants target technology development at multiple Maryland locations including Baltimore, Prince George's, Cecil, and Talbot counties, showcasing a geographically diverse approach to innovation. The projects funded through this initiative present significant implications for both contractors and procurement professionals. With a clear focus on advancing sectors critical to Maryland's economy, involved organizations can expect a plethora of new contracts and partnership opportunities.

The recipient projects are indicative of Maryland's forward-thinking approach. For instance, Alchemity, LLC is receiving $200,000 to develop technology that transforms waste biogas into sustainable fuels, enhancing both emissions reduction efforts and operational reliability. Similarly, Blackbird Laboratories is securing $750,000 to establish a Clinical Laboratory Improvement Amendments (CLIA) Catalyst Facility, a crucial step in elevating diagnostic technologies in healthcare by offering a supportive environment for innovation that directly impacts patient care. Other noteworthy projects include BSA Seafood, which is creating a multifaceted processing hub in Talbot County and CoapTech, Inc., tasked with establishing clean room manufacturing facilities for medical devices, thereby enhancing healthcare infrastructure within the state.

For procurement professionals, these developments represent a significant opportunity to engage with the state’s innovation agenda effectively. Organizations in biotechnology, AI, and clean energy should closely observe Maryland’s investments and actively seek ways to align their offerings with the state’s strategic focus. Engaging with the Department of Commerce and MEDCO will provide avenues for collaboration and maximize access to grant resources.